FDA Inspection 1182109 — OPTILASA, S.L.

OPTILASA, S.L. — FEI 3001022138

The FDA completed an inspection of OPTILASA, S.L. on October 27, 2022 in Madrid. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 27, 2022
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Madrid (Spain)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
312821 CFR 820.90(a)Nonconforming product control
313021 CFR 820.100(a)Lack of or inadequate procedures
316821 CFR 820.198(a)Complaints
342521 CFR 820.50(a)(1)Evaluation and Selection, Suppliers, Contractors, etc.